![]() | |
Clinical data | |
---|---|
Trade names | (none, active metabolite ofRilmazafone) |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChemCID | |
UNII | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
3D model (JSmol) | |
| |
|
Rilmazolam, is abenzodiazepine derivative which acts as asedative andhypnotic drug, and the active metabolite of the drugRilmazafone.[1] It has never been developed for medical uses, yet the aforementioned prodrug is an approved medication inJapan.